Literature DB >> 10622528

Establishment of an in vivo highly metastatic rat hepatocellular carcinoma model.

M Futakuchi1, M Hirose, T Ogiso, K Kato, M Sano, K Ogawa, T Shirai.   

Abstract

We previously found by chance that N-nitrosomorpholine (NMOR) given after a multi-carcinogenic treatment induces liver carcinomas with 56% lung metastasis, and it was confirmed that hepatocellular carcinoma (HCC) with 100% lung metastasis was produced by 24-week treatment with NMOR and additional treatment with diethylnitrosamine (DEN). In the present study, we modified the duration of NMOR to establish an animal model with a simple experimental protocol and an appropriate experimental duration which would facilitate further study of the mechanisms of metastasis and antimetastatic agents. The results revealed DEN exposure followed by a 16-week treatment with NMOR to be a most efficient method for the induction of HCC metastasizing to the lung. Loss of cadherin, demonstrated immunohistochemically, occurred in an early stage of carcinogenesis, and this was reflected in malignant conversion of primary lesions. This model, with its essential similarities to malignant tumor behavior in man, should find application not only for elucidation of the mechanisms underlying metastasis, but also in the development of anti-metastatic agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10622528      PMCID: PMC5926015          DOI: 10.1111/j.1349-7006.1999.tb00695.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  22 in total

1.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

Review 2.  Morphogenetic roles of classic cadherins.

Authors:  M Takeichi
Journal:  Curr Opin Cell Biol       Date:  1995-10       Impact factor: 8.382

3.  Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential.

Authors:  A Raz; C Bucana; W McLellan; I J Fidler
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

4.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

5.  E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.

Authors:  G Mbalaviele; C R Dunstan; A Sasaki; P J Williams; G R Mundy; T Yoneda
Journal:  Cancer Res       Date:  1996-09-01       Impact factor: 12.701

6.  Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes.

Authors:  T Masui; H Nakanishi; K Inada; T Imai; Y Mizoguchi; H Yada; M Futakuchi; T Shirai; M Tatematsu
Journal:  Cancer Lett       Date:  1997-01-15       Impact factor: 8.679

7.  Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice.

Authors:  R Giavazzi; D E Campbell; J M Jessup; K Cleary; I J Fidler
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

8.  Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine.

Authors:  E Weber; P Bannasch
Journal:  Carcinogenesis       Date:  1994-06       Impact factor: 4.944

9.  Metastasizing tumors in rats treated with alkylating carcinogens.

Authors:  W Lijinsky
Journal:  Carcinogenesis       Date:  1995-04       Impact factor: 4.944

10.  Overexpression of P-glycoprotein in rat hepatocellular carcinomas induced with N-nitrosomorpholine.

Authors:  M Volm; H Zerban; J Mattern; T Efferth
Journal:  Carcinogenesis       Date:  1990-01       Impact factor: 4.944

View more
  10 in total

1.  Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.

Authors:  Danièle Taras; Jean-Frédéric Blanc; Anne Rullier; Nathalie Dugot-Senant; Ingrid Laurendeau; Ivan Bièche; Mark Pines; Jean Rosenbaum
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

2.  Modification of an in vivo lung metastasis model of hepatocellular carcinoma by low dose N-nitrosomorpholine and diethylnitrosamine.

Authors:  Hiroko Yoshino; Mitsuru Futakuchi; Young-Man Cho; Kumiko Ogawa; Fumitaka Takeshita; Norio Imai; Seiko Tamano; Tomoyuki Shirai
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 3.  Hepatocellular carcinoma: insight from animal models.

Authors:  Yan Li; Zhao-You Tang; Jin-Xuan Hou
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

4.  Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication.

Authors:  Naomi Hokaiwado; Makoto Asamoto; Mitsuru Futakuchi; Kumiko Ogawa; Satoru Takahashi; Tomoyuki Shirai
Journal:  J Membr Biol       Date:  2007-11-03       Impact factor: 1.843

Review 5.  Experimental models of hepatocellular carcinoma: developments and evolution.

Authors:  Long Wu; Zhao-You Tang; Yan Li
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-28       Impact factor: 4.553

6.  Synergistic effects of curcumin and bevacizumab on cell signaling pathways in hepatocellular carcinoma.

Authors:  Jian-Zhi Gao; Jing-Li DU; Yong-Ling Wang; Jia Li; Li-Xin Wei; Ming-Zhou Guo
Journal:  Oncol Lett       Date:  2014-11-10       Impact factor: 2.967

7.  Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma.

Authors:  Mitsuru Futakuchi; Kumiko Ogawa; Masashi Sano; Seiko Tamano; Fumitaka Takeshita; Tomoyuki Shirai
Journal:  Jpn J Cancer Res       Date:  2002-10

8.  Establishment of rat liver cancer cell lines with different metastatic potential.

Authors:  Lei Song; Jian-Gang Zhang; Long Zheng; Xu Feng; Jie Hou; Huan-Ling Zhang; Shu-Feng Liu
Journal:  Sci Rep       Date:  2020-05-20       Impact factor: 4.379

9.  Heparanase Contributes To Trans-Endothelial Migration of Hepatocellular Carcinoma Cells.

Authors:  Xiaopeng Chen; Wen Jiang; Chaofu Yue; Wenjun Zhang; Chaogang Tong; Dafei Dai; Bin Cheng; Chen Huang; Linming Lu
Journal:  J Cancer       Date:  2017-09-16       Impact factor: 4.207

Review 10.  Genetically Engineered Mouse Models for Liver Cancer.

Authors:  Kyungjoo Cho; Simon Weonsang Ro; Sang Hyun Seo; Youjin Jeon; Hyuk Moon; Do Young Kim; Seung Up Kim
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.